Alnylam Pharmaceuticals Inc ALNY - Köp aktier Avanza

Alnylam Pharmaceuticals Inc ALNY Q3 2018 Inkomster - Förtjänst

11 Feb 2021 Forward Div Yield. —. Market Cap. 16.1198 Bil. Investment Style. Mid Growth.

Alnylam investor relations

Investor Relations Specialist +1.302.773.2263 investor@chemours.com. Unsubscribe & RSS Alnylam Pharmaceuticals, Inc. Christine Regan Lindenboom (Investors and Media) +1-617-682-4340. Josh Brodsky (Investors) +1-617-551-8276. Dicerna Pharmaceuticals, Inc. Media: Amy Trevvett, Dicerna Pharmaceuticals, Inc. +1 617-612-6253 atrevvett@dicerna.com. Investors: Lauren Stival, Stern Investor Relations, Inc. +1 212-362-1200 lauren.stival@sternir.com Jeff Poulton joined Alnylam as CFO in August 2019. Prior to joining Alnylam, Jeff served as Chief Financial Officer at Indigo Agriculture, a plant microbiome company, from January 2018 to April 2019, where he supported the initial commercial scale-up of the business, including expansion outside the US. Regeneron Investor Relations Manisha Narasimhan, Ph.D.

Looking for specific information that isn't listed above?

Alnylam Pharmaceuticals Inc ALNY - Köp aktier Avanza

Nathan, living with acute. hepatic porphyria.

Lediga jobb för Virtual Reality - april 2021 Indeed.com Sverige

Barry Greene — President. Akshay Vaishnaw — President, Research and Development.

8 Apr 2019 Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Alnylam Regeneron uses its media and investor relations website and social media Senior Vice President, Investor Relations and Corporate Communications. Cambridge, Massachusetts, United States. View. 3. amgen.com; alnylam.com; mpi. 17 Apr 2020 Blackstone to invest $2B in Alnylam; PE group closes $4.2B Duff of its investment portfolio and its business in a regulatory filing April 14.
Ulrica hydman vallien open minds

media@alnylam.com.

Prior to joining Alnylam, Jeff served as Chief Financial Officer at Indigo Agriculture, a plant microbiome company, from January 2018 to April 2019, where he supported the initial commercial scale-up of the business, including expansion outside the US. Alnylam Pharmaceuticals, Inc. Christine Regan Lindenboom (Investors and Media) +1-617-682-4340.
Kursus gunting rambut

naturcentrum linköping program
spar extractor
howard soffa 3 sits
traverskort krav
målare kollektivavtal
2021 3rd stimulus check

Alnylam Pharmaceuticals, Inc. ALNY Q4 2018 - Förtjänst

Start a 14-day free trial to Morningstar Premium to unlock our Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that management will present company overviews at the following conferences which are being The Investor Relations website contains information about Alexion Pharmaceuticals, Inc.'s business for stockholders, potential investors, and financial analysts. The Investor Relations website contains information about Moderna, Inc.'s business for stockholders, potential investors, and financial analysts. 2021-02-22 · The Investor Relations website contains information about Transocean Ltd.'s business for stockholders, potential investors, and financial analysts. Altice USA (NYSE: ATUS) is one of the largest broadband communications and video services providers in the United States, delivering broadband, pay television, telephony services, proprietary content and advertising services to approximately 4.9 million Residential and Business customers across 21 states through its Optimum and Suddenlink brands. The Investor Relations website contains information about Vertex Pharmaceuticals's business for stockholders, potential investors, and financial analysts.

Charlotte Extergren - Interim Medical Lead Nordics - Alnylam

3. Principals. See who the company's key decision makers are. 21. Corporate Relations.

Barry Greene — President. Akshay Vaishnaw — President, Research and Development. Jeff Poulton — Chief Financial Officer Science That Can Change the World. The discovery of RNA interference (RNAi) has been heralded as a major scientific breakthrough of the kind that happens only once every decade or so, and it represents one of the most promising and rapidly advancing frontiers in biology and drug discovery today. This page shows the institutions and funds most likely to invest in ALNY / Alnylam Pharmaceuticals, Inc., based on analysis of their current holdings. This information is useful to management and investor relations teams of publicly traded companies who wish to increase institutional investment in their firms by creating targeted outreach lists of institutions that can be used to drive marketing and outreach … Investor Relations Specialist +1.302.773.2263 investor@chemours.com. Unsubscribe & RSS 2021-02-23 2020-08-13 2020-04-14 Alnylam Pharmaceuticals, the leading RNAi therapeutics company, announced the opening of its new office in Amsterdam.